Welcome
to Bench2Batch
Bench2Batch™ provides expert CMC and process validation support across the product lifecycle —
from tech transfer and characterization to PPQ, CPV, and APQR.
Bench2Batch™ provides end-to-end CMC, MSAT, and validation expertise to help biopharmaceutical companies scale confidently from development to commercial manufacturing. Our services are grounded in science, risk-based thinking, and regulatory expectations—delivered by experienced practitioners who have executed these activities at scale.
What We Do
( OUR SOLUTION)
End-to-end Phase appropriate CMC support
WHY BENCH2BATCH™
Bench2Batch is led by Naveenganesh Muralidharan,
Biopharmaceutical leader with 20+ years of experience in GMP manufacturing, tech transfer, and end-to-end process validation across biologics, gene therapy, oligonucleotides, and RNA modalities. Proven in advancing programs from early development through commercial launch, leading MSAT, CQV, and process scale-up with strong FDA/EMA compliance. Extensive expertise in Upstream, Downstream, batch record authoring/review, data trending, deviation and change control, and on-site CMO campaign support. Recognized for first-time-right execution, cross-functional leadership, and driving robust supply chains and secondary vendor transfers to ensure reliable global manufacturing.
You get more than documentation — you get a true technical partner.
Technical Insights
On-Line Bioreactor Scale-Up & Scale Down Tools
These online bioreactor calculators simplify the process of scaling up or down between bench and production scale. They offer tools to predict pCO2, assess shear from impellers and sparging, and
calculate OTR and KLa. This helps users optimize process conditions and improve scalability
across different reactor sizes.
